DiaSorin S.p.A.
DSRLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,765 | $5,032 | $7,936 | $10,193 |
| - Cash | $344 | $280 | $242 | $403 |
| + Debt | $1,014 | $1,193 | $1,352 | $1,395 |
| Enterprise Value | $6,435 | $5,945 | $9,047 | $11,185 |
| Revenue | $1,185 | $1,148 | $1,361 | $1,238 |
| % Growth | 3.2% | -15.6% | 10% | – |
| Gross Profit | $782 | $741 | $901 | $825 |
| % Margin | 65.9% | 64.6% | 66.2% | 66.6% |
| EBITDA | $399 | $333 | $480 | $505 |
| % Margin | 33.7% | 29% | 35.2% | 40.8% |
| Net Income | $188 | $160 | $241 | $311 |
| % Margin | 15.9% | 13.9% | 17.7% | 25.1% |
| EPS Diluted | 3.37 | 2.87 | 4.15 | 5.4 |
| % Growth | 17.4% | -30.8% | -23.1% | – |
| Operating Cash Flow | $359 | $312 | $389 | $401 |
| Capital Expenditures | -$120 | -$45 | -$114 | -$117 |
| Free Cash Flow | $239 | $266 | $276 | $283 |